tradingkey.logo

Conmed Corp

CNMD
View Detailed Chart
44.710USD
+0.760+1.73%
Close 11/11, 16:00ETQuotes delayed by 15 min
1.38BMarket Cap
21.60P/E TTM

Conmed Corp

44.710
+0.760+1.73%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.73%

5 Days

-2.19%

1 Month

+4.76%

6 Months

-21.67%

Year to Date

-34.67%

1 Year

-40.28%

View Detailed Chart

TradingKey Stock Score of Conmed Corp

Currency: USD Updated: 2025-11-11

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Conmed Corp's Score

Industry at a Glance

Industry Ranking
51 / 209
Overall Ranking
124 / 4608
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 6 analysts
Hold
Current Rating
54.000
Target Price
+22.87%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Conmed Corp Highlights

StrengthsRisks
CONMED Corporation is a medical technology company, which provides surgical devices and equipment for minimally invasive procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 25.02% year-on-year.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 18.63%.
Fairly Valued
The company’s latest PE is 21.62, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 36.52M shares, decreasing 13.64% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 18.13K shares of this stock.

Conmed Corp News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Conmed Corp Info

CONMED Corporation is a medical technology company, which provides surgical devices and equipment for minimally invasive procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
Ticker SymbolCNMD
CompanyConmed Corp
CEOMr. Patrick J. (Pat) Beyer
Websitehttps://www.conmed.com/
KeyAI